Related Experiment Video
Updated: Jul 15, 2025

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Superior Vena Cava Flow in Children With Attention Deficit Hyperactivity Disorder
Muhammed Karabulut1, Kübra Yıldırım2
1Department of Paediatric Cardiology, Clinical of Paediatric Health and Diseases, Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Insights
This study found that children with Attention Deficit/Hyperactivity Disorder (ADHD) have higher superior vena cava (SVC) flow, an indicator of cerebral blood flow. Methylphenidate (MPH) treatment reduced this flow, suggesting its potential as a biomarker for ADHD diagnosis and treatment.
Area of Science:
- Neuroscience
- Pediatrics
- Cardiovascular Physiology
Background:
- Attention Deficit/Hyperactivity Disorder (ADHD) is a common childhood neurobehavioral disorder with ongoing research into its pathophysiology.
- Cerebral venous circulation in ADHD has not been extensively studied, nor has the impact of methylphenidate (MPH) on it.
- Superior Vena Cava (SVC) flow, measured noninvasively via transthoracic echocardiography, serves as an indirect indicator of cerebral venous flow.
Purpose of the Study:
- To investigate cerebral venous circulation in children with ADHD by measuring SVC flow.
- To evaluate the effect of osmotic-release oral system (OROS)-MPH treatment on SVC flow in ADHD patients.
Main Methods:
- Transthoracic echocardiography was used to measure SVC flow.
- The study included 44 healthy children and 40 children diagnosed with ADHD.
- SVC flows were recorded in healthy children and in ADHD patients before and after OROS-MPH treatment initiation.
Main Results:
- ADHD patients exhibited significantly higher SVC flow compared to healthy controls.
- OROS-MPH treatment led to a significant reduction in SVC flow among ADHD patients.
- Patients with inadequate response to MPH treatment did not show a decrease in SVC flow.
Conclusions:
- This study is the first to demonstrate an association between increased SVC flow and ADHD in children.
- MPH treatment effectively reduced elevated SVC flow in ADHD patients.
- Noninvasively measured SVC flow may serve as a valuable biomarker for ADHD diagnosis and treatment monitoring in future research.
Objective:
Attention deficit/hyperactivity disorder (ADHD), whose definition, diagnosis and treatment has been the subject of debate in the scientific community for a long time, is the most common neurobehavioral disorder in childhood. There are many studies on the pathophysiology of attention deficit. However, there is no study in the literature based on direct or indirect measurement of cerebral venous circulation in ADHD, and the effect of methylphenidate (MPH) treatment on cerebral venous circulation. Therefore, it was aimed to noninvasively measure superior vena cava (SVC) flow, which is an indirect indicator of cerebral venous flow, by transthoracic echocardiography in patients with ADHD.
Methods:
In the study, 44 healthy children, and 40 ADHD patients who were planned to start on osmotic-release oral system (OROS)- MPH were included. SVC flows were measured in healthy children and before and after drug therapy of ADHD patients.
Results:
SVC flow was found to be higher in ADHD patients compared to healthy children. A significant decrease was found in SVC flow of ADHD patients after OROS-MPH treatment. There was no decrease in SVC flow of patients who did not respond adequately to MPH treatment.
Conclusion:
This first study of SVC flow in children with ADHD showed that ADHD was associated with increased SVC flow and MPH treatment had a reducing effect on this increased SVC flow. We believe that noninvasive, easily measurable, and reproducible SVC flow may be a new focus of interest for future comprehensive studies as a biomarker to support clinical evaluation in the diagnosis and treatment follow-up of ADHD patients.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Oppositional Defiant Disorder
Diagnostic Criteria and...
Conduct Disorder
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.